Clinical Trials Directory

Trials / Unknown

UnknownNCT05803226

Slow Art Plus: A Single Session Art Gallery-based Intervention for Mental Health Promotion

Slow Art Plus: Developing and Piloting a Single Session Art Gallery-based Intervention for Mental Health Promotion Via a Mixed Method Waitlist Randomized Control Trial (RCT)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Nanyang Technological University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Utilizing a Participatory Action Research (PAR) paradigm, this 12-month study will adopt a mixed method Waitlist Randomized Control Trial (RCT) with a built-in acceptability and feasibility study to test the efficacy of Slow Art Plus in reducing stress and empowering self-care among 200 participants.

Detailed description

The specific objectives are in four-folds: 1) To develop a standardized 90-minute single-session Slow Art Plus programme that integrates: (a) slow looking; (b) mindfulness meditation; (c) self-compassion activities; (d) reflective-creative expressions; and (e) dyadic sharing, to form a holistic mental health promotion intervention; 2) To assess the effectiveness of Slow Art Plus for reducing participants' perceived stress (primary outcomes); 3) To assess the effectiveness of Slow Art Plus for enhancing participants' self-awareness, self-care capacity, psychological resilience, and quality of life (secondary outcomes); and 4) To assess the feasibility and acceptability of the standardized Slow Art Plus protocol for large scale implementation in Singapore and greater Asia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSlow Art PlusSlow Art Plus involved a full 90-minute engagement, one that is built upon the existing Slow Art programme with added layers of mindfulness and self-compassion practices, as well as a response art activity that fosters symbolic dialogue and an emotional aesthetic experience between participants and the selected artwork.

Timeline

Start date
2022-07-14
Primary completion
2023-12-31
Completion
2024-12-31
First posted
2023-04-07
Last updated
2023-04-07

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05803226. Inclusion in this directory is not an endorsement.